Moderna SG&A Expense (TTM) Analysis

Moderna Inc (MRNA)

121.29 -3.71 (-2.97%) USD | NASDAQ | May 06, 13:54

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	1.518B
December 31, 2023	1.549B
September 30, 2023	1.454B
June 30, 2023	1.29B
March 31, 2023	1.169B
December 31, 2022	1.132B
September 30, 2022	958.00M
June 30, 2022	848.00M
March 31, 2022	758.00M
December 31, 2021	567.00M
September 30, 2021	445.00M
June 30, 2021	325.00M

Date	Value
March 31, 2021	241.00M
December 31, 2020	188.00M
September 30, 2020	135.09M
June 30, 2020	115.26M
March 31, 2020	106.75M
December 31, 2019	110.00M
September 30, 2019	121.94M
June 30, 2019	112.29M
March 31, 2019	105.19M
December 31, 2018	94.25M
September 30, 2018	72.13M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

106.75M

Minimum

Mar 2020

1.549B

Maximum

Dec 2023

657.17M

Average

506.00M

Median

SG&A Expense (TTM) Benchmarks